Breaking News
March 21, 2019 - MIT announces creation of the Alana Down Syndrome Center
March 21, 2019 - Next-generation LVAD device clinically superior, safer for heart failure patients
March 21, 2019 - Allergan Announces FDA Approval of Avycaz (ceftazidime and avibactam) for Pediatric Patients
March 21, 2019 - Mutations in noncoding genes could play big role in regulating cancer, study finds
March 21, 2019 - A medical student’s thoughts on Match Day
March 21, 2019 - Are eggs good or bad for you?
March 21, 2019 - New analysis reveals precision oncology insights for colorectal cancer
March 21, 2019 - Pollutants appear to weaken immune system and increase pathogen virulence
March 21, 2019 - Researchers develop and validate scale for rating severity of mononucleosis
March 21, 2019 - Scientists identify generation of key immune response in mice on introducing solid food
March 21, 2019 - New nanomaterial could restore internal structure of damaged bones
March 21, 2019 - Selective destruction of prostate tumor as effective as complete prostate removal
March 21, 2019 - 2011 to 2015 Saw Increase in Psychiatric ED Visits for Youth
March 21, 2019 - Tapeworm drug targets common vulnerability in tumor cells
March 21, 2019 - Off the beaten path for global health residency
March 21, 2019 - European Parliament’s report calls on EU to develop policies to regulate endocrine-disrupting chemicals
March 21, 2019 - Women with undiagnosed diabetes in pregnancy more likely to experience stillbirths
March 21, 2019 - Fish consumption can help prevent asthma, study reveals
March 21, 2019 - Royal Holloway professors to lead new to research into curing Neurofibromatosis type 1
March 21, 2019 - NSF offers grant to improve treatment approaches for pelvic organ prolapse
March 21, 2019 - Your Apple Watch Might Help Spot a Dangerous Irregular Heartbeat
March 21, 2019 - Research team uncovers critical new clues about what goes awry in autistic brains
March 21, 2019 - From March Madness to medicine with help from mentors
March 21, 2019 - Mental health disorders among young adults may be on the increase
March 21, 2019 - New study examines smarter automatic defibrillator
March 21, 2019 - UC Riverside research shows how natural selection favors cheaters
March 21, 2019 - Mother’s diet during pregnancy can impact lung-specific genes of her offspring
March 21, 2019 - AeroForm Tissue Expanders makes breast reconstruction after mastectomy more comfortable
March 21, 2019 - New project focuses on creating more responsive, intuitive prosthetics
March 21, 2019 - New case study describes adolescent patient with rapid-onset schizophrenia and Bartonella infection
March 21, 2019 - Umass Amherst food scientist honored with 2019 Young Scientist Research Award
March 21, 2019 - Smell of skin could lead to early diagnosis for Parkinson’s
March 21, 2019 - Difference in brain connectivity may explain autism spectrum disorder
March 21, 2019 - Untangling the microbiome — with statistics
March 21, 2019 - Human microbiome metabolites enhance colon injury by enterohemorrhagic E. coli, study shows
March 21, 2019 - Written media can improve citizens’ understanding of palliative care
March 21, 2019 - New research aims to find how asthma symptoms are aggravated
March 21, 2019 - New $9.7 million NIH grant project seeks to improve hearing restoration
March 21, 2019 - Researchers measure brain metabolite levels in people with mild memory problems
March 21, 2019 - FDA approves first drug for treatment of postpartum depression in adult women
March 20, 2019 - Gene editing and designer babies experiments face global moratorium
March 20, 2019 - Major scientific study of wound care dressings wins ‘Best Clinical or Preclinical Research Award’
March 20, 2019 - Biohaven Enrolls First Patient In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole
March 20, 2019 - Big data study identifies drugs that increase risk of psychosis in youth with ADHD
March 20, 2019 - Mystery novel and dream spur key scientific insight into heart defect | News Center
March 20, 2019 - Study measures impact of policies designed to reduce air pollution in two mega-cities
March 20, 2019 - Mild sleep apnea during pregnancy changes sugar levels and may affect infant growth patterns
March 20, 2019 - SSB and Novasep collaborate to develop new membrane chromatography systems
March 20, 2019 - Leaky valve repair improves quality of life in heart failure patients
March 20, 2019 - Diattenuation Imaging offers structural information of difficult to access brain regions
March 20, 2019 - Early sports specialization linked to increased injury rates during athletic career
March 20, 2019 - Study brings clarity about milk intake for children with Duarte galactosemia
March 20, 2019 - Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
March 20, 2019 - Maternal smoking during pregnancy increases risk of ADHD among offspring up to three-fold
March 20, 2019 - Pioneering pediatric kidney transplant surgeon Oscar Salvatierra dies at 83 | News Center
March 20, 2019 - F.D.A. Approves First Drug for Postpartum Depression
March 20, 2019 - TB remains a major public health challenge in the European region
March 20, 2019 - Most pills contain common allergens, warn experts
March 20, 2019 - Researchers discover previously unknown mechanism by which cells can sense oxygen
March 20, 2019 - World’s leading source of data on diagnosis, treatments for aortic dissection
March 20, 2019 - Breast cancer relapse predictor may soon be a reality
March 20, 2019 - Researchers identify origin of chronic pain in humans
March 20, 2019 - Two-drug combinations containing calcium channel blocker significantly lowers BP
March 20, 2019 - King’s scientists to monitor air quality exposure of 250 children
March 20, 2019 - Active substance from plant could turn into a ray of hope against eye tumors
March 20, 2019 - Preventative cardioverter defibrillator implantation is of little benefit to kidney dialysis patients
March 20, 2019 - New method based on neurofeedback may reduce anxiety
March 20, 2019 - Study explores whether alcohol consumption can have an effect on arthritis
March 20, 2019 - Merck to collaborate with GenScript for plasmid and virus manufacturing in China
March 20, 2019 - FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression
March 20, 2019 - Study examines long-term opioid use in patients with severe osteoarthritis
March 20, 2019 - Retired Stanford professor Edward Rubenstein, pioneer in intensive care medicine, dies at 94 | News Center
March 20, 2019 - Aaron Diamond AIDS Research Center to Join Columbia University
March 20, 2019 - Call for halt to human gene editing and designer babies experiments
March 20, 2019 - Study illuminates how hot spots of genetic variation evolved in the human genome
March 20, 2019 - Roundworm study suggests alternatives for treatment of schizophrenia
March 20, 2019 - Sphingotec reports new applications of bio-ADM at 39th ISICEM
March 20, 2019 - Preventing falls through free community-based screenings for older adults
March 20, 2019 - AAOS: Supplement Use Low in Patients With Osteoporosis, Hip Fracture
March 20, 2019 - Does intensive blood pressure control reduce dementia?
At Risk for an Opioid OD? There’s an App for That

At Risk for an Opioid OD? There’s an App for That

image_pdfDownload PDFimage_print

WEDNESDAY, Jan. 9, 2019 — Drug users suffering an opioid overdose might soon have access to an unusual lifeline — a smartphone app.

University of Washington researchers have developed an app that can detect when a person’s breathing dangerously slows or stops.

The Second Chance app accurately detected opioid overdose symptoms more than nine times out of 10 in experimental tests, which took place at a facility in Vancouver, Canada, where addicts can legally bring illicit drugs and inject them under medical supervision.

The app’s developers are applying for approval from the U.S. Food and Drug Administration to market the phone software as a potentially lifesaving monitor for people taking opioids, said researcher Shyamnath Gollakota. He is an associate professor with the University of Washington School of Computer Science and Engineering in Seattle.

“Given the importance of the problem and the number of people dying, we are hoping to get fast-track status with the FDA so we can get this as soon as possible to the market,” Gollakota said. He estimated that the app could be available within a year if its approval is fast-tracked.

More than 70,000 drug overdose deaths occurred in 2017, the most recent year for which stats are available, according to the U.S. Centers for Disease Control and Prevention. Opioids were involved in 47,600 of those deaths, or nearly 68 percent.

An opioid overdose kills a person by slowing and eventually stopping their breathing, explained senior researcher Dr. Jacob Sunshine, an anesthesiologist with the University of Washington Medical Center.

Opioid overdoses can be reversed by the drug naloxone, but “unfortunately this isn’t happening enough, and that’s resulted in people dying in extremely large numbers,” Sunshine said. “More than 115 people a day are dying from opioid overdose in the U.S.”

To help detect an overdose, the research team developed an app that essentially turns a smartphone into an active sonar system, said lead researcher Rajalakshmi Nandakumar, a Ph.D. candidate with the University of Washington’s School of Computer Science and Engineering.

The phone continuously transmits inaudible sound waves. “These signals get reflected off the human body, specifically the chest,” Nandakumar said. “When the person is breathing, their chest motion is captured by these reflections and recorded in the microphone. You can monitor the breathing motion of a person just using the smartphone.”

To test the app, the researchers partnered with the Insite supervised injection facility, the first legal supervised narcotics consumption site in North America. At the center, drug users are allowed to inject street drugs in the presence of nurses and staff trained in overdose intervention.

The team recruited 94 opioid users at Insite to test the app, with the smartphone placed on a table within a meter of the participants.

During testing, 47 users experienced a dangerously low breathing rate of seven or fewer breaths per minute, 49 stopped breathing for a significant period of time, and two had a drug overdose that required medical treatment.

About 90 percent of the time, the app correctly identified breathing problems that foreshadow overdoses, the researchers reported.

Further testing the app, researchers asked 20 additional volunteers to actually undergo a “simulated” drug overdose. These simulated events took place in an operating room at the UW Medical Center, and involved healthy participants previously scheduled to undergo elective surgery.

Consenting patients received anesthetics that led to 30 seconds of slow or stopped breathing. The smartphone was placed on a surgical stand about a meter away from the patient.

The app correctly predicted 19 out of 20 simulated overdoses. In the case of the single failure, the patient’s breathing rate was just above the threshold at which an alarm would sound, the researchers noted.

The idea is that the app would sound an alarm if it detects slowed or stopped breathing in an opioid user, the study authors explained. The person would need to reach over and let the app know that they are OK.

“If they fail to interact with it, then it would contact either a loved one who has naloxone or emergency services,” to get the person the lifesaving treatment they need, Nandakumar said.

Although the technology is promising, it still needs more testing before it’s ready for widespread use, said Fred Muench, president and CEO of the Partnership for Drug-Free Kids.

Muench noted that the settings in which the app was tested were all very tightly controlled.

“The main problem with mobile apps and technology is when you test it in a controlled setting, the majority of the time it does not generalize to the real world,” Muench said.

For example, how well would the app work if a person’s phone is in their pocket, which is where most folks keep theirs, he asked.

“This is a very early conceptual model that has the opportunity for growth and the opportunity to make an impact years down the line,” Muench said. “I wouldn’t be willing to endorse anything until it was tested in the real world,” possibly in people who naturally suffer from sleep apnea or breathing disorders.

The study was published Jan. 9 in the journal Science Translational Medicine.

More information

The U.S. Centers for Disease Control and Prevention has more about drug overdose deaths.

© 2019 HealthDay. All rights reserved.

Posted: January 2019

Tagged with:

About author

Related Articles